Theo Smart

I am an activist and medical writer who joined ACT UP New York in 1988 and have more than twenty years of experience writing about HIV treatment for organisations including ACT UP's Treatment & Data Committee, TAG, the PWA Health Group, GMHC, the Physician's Research Network in New York and AmFAR. After the World AIDS Conference in Durban, South Africa, I moved to Cape Town, Africa, where I became involved in a number of projects including serving as editor of the HIV and AIDS Treatment in Practice (HATIP) and www.aidsmap.com, and working to support National Networks of People Living With HIV participating in the HIV Leadership through Accountability Programme (www.hivleadership.org). At present, I work as a freelance writer/editor primarily interested in the scale up and delivery of patient-centred HIV/TB, improved MCH and other primary health care and treatment services in resource limited settings. I believe access to quality healthcare is a human right and believe that health systems and healthcare workers should be empowered to deliver it.

Fatty liver disease found to be very common in both younger and older people living with HIV according to cohort study in diverse population

  [Lance Sherriff assisted in the transcription and compilation of this article.] Fatty liver disease (hepatic steatosis) was found to be very common among people living with HIV in a cross-sectional study involving 160 people on antiretroviral treatment, according to data presented at the 9th International HIV and Aging Workshop last week in New York […]

Fatty liver disease found to be very common in both younger and older people living with HIV according to cohort study in diverse population Read More »

Even newer NRTIs (anti-HIV drugs) found to cause mitochondrial damage in muscle

[Lance Sherriff assisted in the transcription and compilation of this article.] Mitochondria (the small organelles in cells that are critical for energy production) within the muscle fibers of antiretroviral-treated people living with HIV may be significantly damaged, according to a study presented last week in New York at the HIV and Aging Workshop by researchers

Even newer NRTIs (anti-HIV drugs) found to cause mitochondrial damage in muscle Read More »

Linking people living with HIV and aging issues to appropriate care: Efforts from New York City’s Department of Health, ACT UP and NATAP

  Many of the aging people living with HIV suffering the most may not be able to defend themselves.  Key points: An ACT UP working group is starting to compile a list of HIV care facilities with experience treating long-term survivors and people living with HIV over the age of 50 who are experiencing aging-related

Linking people living with HIV and aging issues to appropriate care: Efforts from New York City’s Department of Health, ACT UP and NATAP Read More »

The high risk of frailty in middle-aged people living with HIV

  Frailty, the condition of depleted energy and physiological decline that is often seen in the elderly and that makes them less capable of recovering from illness, accidents and the stresses of life, has been reported to be significantly more common in people living with HIV — even in middle-aged people on antiretroviral treatment (ART)

The high risk of frailty in middle-aged people living with HIV Read More »

AIDS 2018: Disappointing results from vedolizumab study re durable suppression off antiretroviral treatment strategy

  Last week, I retweeted a press release from the NIH about a presentation that Tony Fauci was going to make at the AIDS Conference, which featured the lead quote “Durable control of HIV infection in the absence of antiretroviral therapy is a feasible concept that deserves vigorous pursuit.” This was referring to the ‘cure’

AIDS 2018: Disappointing results from vedolizumab study re durable suppression off antiretroviral treatment strategy Read More »

TB2016: The HIV and TB communities’ causes are inextricably linked: Success happens together

TB2016 was a two-day conference dedicated exclusively to TB that immediately preceded the 21st International AIDS Conference (AIDS 2016) in Durban, South Africa. It convened TB implementers, TB scientists, infectious disease clinicians and scientists, health policy makers, and advocacy — but was held in conjunction with AIDS2016 in the hope that it would attract many

TB2016: The HIV and TB communities’ causes are inextricably linked: Success happens together Read More »

AIDS 2016: Bringing treatment programmes to scale in Africa

In the last 16 years, countries in sub-Saharan Africa have created the largest treatment programs in the world; their activists negotiated access and prices globally in its courts; and their implementers have provided the innovations in delivery to ensure coverage at community level.  This is not just reflected in treatment numbers (10.7 million) but in

AIDS 2016: Bringing treatment programmes to scale in Africa Read More »

Theo Smart’s Partial Publications/Portfolio list (a work in progress)

Major projects with published output accessible online, in order of the most recent (see end for freelance news coverage) Parent Project Muscular Dystrophy Medical writer: Submission of a Proposed Draft Guidance for Industry on Developing Drugs for Treatment of Duchenne Muscular Dystrophy; Establishment of a Public Docket (see here) Cover letter for submission: The Draft

Theo Smart’s Partial Publications/Portfolio list (a work in progress) Read More »